课题基金 / 基金详情

Admin-Core-001

Admin-Core-001
管理核心-001
批准号:
10707661
负责人:
TZYY-CHOOU WU
金额:
$19.99万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
已结题
起止时间:
2022-09-01 至 2024-08-31
关键词:

项目摘要

项目成果

TZYY-CHOOU WU的其他基金

相似基金

相关文献

中文摘要
翻译
项目摘要/摘要管理/沟通核心(核心A)负责促进所有项目活动的协调和监督,并负责在孢子内部传播信息和进行外部互动。该核心旨在实现低成本、高效率的管理和沟通,以便将资金集中用于研究活动。核心A包括一名基础科学主任(t.c。Wu)和临床研究主任(Dr. Warner Huh)。吴博士负责协调基础科学工作和个人项目的协调。Huh博士在Core的背景下监督患者识别,登记和患者监测。Core的管理组件遵循管理活动的组织结构图。研究监督将通过以下方式进行:1)研究项目小组,2)研究项目领导委员会,3)核心调查委员会,4)发展研究项目计划,5)职业提升委员会,6)中央孢子指导委员会。此外,内部和外部咨询委员会向指导委员会提供正式评价和报告。该资源资助临床研究协调员与其他核心以及每个单独项目的人员进行交互,以确保所有患者信息、标本和结果被正确收集并记录在计算机数据库中。核心A也资助病人倡导者,他们从独特的角度对各种《孢子》活动提供宝贵的反馈。数据安全监测委员会将提供对患者安全、不良事件以及数据管理和保密的适当监测。核心的通信组件是针对孢子内,孢子间和国家癌症研究所的研究活动。核心协调必要的项目互动,包括准备SPORE的申请和进度报告,所有计划和评估活动,安排和宣传SPORE活动,协调咨询委员会会议,制作年度报告和执行预算事项分析。
英文摘要
Project Summary/Abstract The Administration/Communication Core (Core A) is responsible for facilitating the coordination and oversight of all Program activities and for disseminating information within the SPORE and for external interactions. The Core is designed for low-cost, yet efficient administration and communication in order to focus funds on research activities. Core A includes a basic science director (Dr. T.-C. Wu) and a clinical research director (Dr. Warner Huh). Dr. Wu is responsible for coordinating basic scientific efforts and the coordination of individual projects. Dr. Huh oversees patient identification, enrollment, and patient monitoring in the context of the Core. The administrative component of the Core follows an organizational diagram for management activities. Monitoring of research will occur via: 1) Research Project Teams, 2) Committee of Research Project Leaders, 3) Core Investigators Committee, 4) Developmental Research Projects Program, 5) Career Enhancement Committee, and 6) the central SPORE Steering Committee. Furthermore, the Internal and External Advisory Boards provide formal evaluations and reports to the Steering Committee. This resource funds a Clinical Research Coordinator who interacts with the other cores as well as with personnel from each individual project to ensure that all patient information, specimens, and results are properly collected and recorded in the computerized database. Core A also funds patient advocate(s), who provide invaluable feedback on various SPORE activities from a unique perspective. Appropriate monitoring of patient safety, adverse events, and data management and confidentiality will be provided by the data safety monitoring boards. The communication component of the Core is directed at intra-SPORE, inter-SPORE, and National Cancer Institute research activities. The Core coordinates essential Program interactions including preparing applications and progress reports for the SPORE, all planning and evaluation activities, arranging and publicizing SPORE activities, coordinating advisory committee meetings, producing annual reports and performing analysis of budgetary matters.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Development of Novel Spontaneous HPV Cervicovaginal Carcinoma Models for Cancer Immunotherapy
  • 批准号:
    10374864
  • 项目类别:
  • 资助金额:
    $57.12万
  • 财政年份:
    2019
  • 负责人:
    TZYY-CHOOU WU
  • 依托单位:
Development of Novel Spontaneous HPV Cervicovaginal Carcinoma Models for Cancer Immunotherapy
  • 批准号:
    10618787
  • 项目类别:
  • 资助金额:
    $57.08万
  • 财政年份:
    2019
  • 负责人:
    TZYY-CHOOU WU
  • 依托单位:
Ovarian cancer gene therapy using HPV pseudovirion
  • 批准号:
    9026581
  • 项目类别:
  • 资助金额:
    $33.62万
  • 财政年份:
    2014
  • 负责人:
    TZYY-CHOOU WU
  • 依托单位:
(2/2) Howard University/Johns Hopkins Partnership in HPV-Related Cancer Research
  • 批准号:
    9330697
  • 项目类别:
  • 资助金额:
    $17.97万
  • 财政年份:
    2014
  • 负责人:
    TZYY-CHOOU WU
  • 依托单位:
国内基金
海外基金
胆固醇羟化酶CH25H非酶活依赖性促进乙型肝炎病毒蛋白Core及Pre-core降解的分子机制研究
  • 批准号:
    82371765
  • 项目类别:
    面上项目
  • 资助金额:
    50万元
  • 批准年份:
    2023
  • 负责人:
    谭广云
  • 依托单位:
锕系元素5f-in-core的GTH赝势和基组的开发
  • 批准号:
    22303037
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    30万元
  • 批准年份:
    2023
  • 负责人:
    鲁俊波
  • 依托单位:
基于合成致死策略搭建Core-matched前药共组装体克服肿瘤耐药的机制研究
  • 批准号:
    --
  • 项目类别:
    --
  • 资助金额:
    52万元
  • 批准年份:
    2022
  • 负责人:
    孙丙军
  • 依托单位:
鼠伤寒沙门氏菌LPS core经由CD209/SphK1促进树突状细胞迁移加重炎症性肠病的机制研究
  • 批准号:
    --
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    30万元
  • 批准年份:
    2022
  • 负责人:
    叶成林
  • 依托单位: